Discovery and identification of potential biomarkers of papillary thyroid carcinoma
Y Fan, L Shi, Q Liu, R Dong, Q Zhang, S Yang, Y Fan… - Molecular Cancer, 2009 - Springer
… Wilcoxon rank sum test analysis assessed the relative importance of each peak in the …
non-cancer controls with a sensitivity of 95.15% and a specificity of 93.97% in the blind testing set. …
non-cancer controls with a sensitivity of 95.15% and a specificity of 93.97% in the blind testing set. …
Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients
M Schlumberger, A Hitzel, ME Toubert… - The Journal of …, 2007 - academic.oup.com
… reported by the manufacturers; and 3) for the two most sensitive assays, the cutoff maximizing
the sum of sensitivity plus specificity deduced from the receiver operating characteristic (…
the sum of sensitivity plus specificity deduced from the receiver operating characteristic (…
[HTML][HTML] Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper.
L Giovanella, PM Clark, L Chiovato, L Duntas… - European journal of …, 2014 - sonar.ch
… of new highly sensitive Tg assays with improved analytical sensitivity and precision at low …
of thyroid tissue without the need for TSH stimulation. Use of these highly sensitive Tg assays …
of thyroid tissue without the need for TSH stimulation. Use of these highly sensitive Tg assays …
… up of patients with low-risk papillary thyroid carcinoma and undetectable basal serum thyroglobulin after ablation measured with a sensitive assay: a prospective study
PWS Rosario, JBN Dos Santos… - Hormone and …, 2013 - thieme-connect.com
… papillary thyroid carcinoma (PTC) and undetectable basal Tg measured with sensitive assays
… low risk for recurrence; undetectable basal Tg (functional sensitivity of 0.1 ng/ml) 6 months …
… low risk for recurrence; undetectable basal Tg (functional sensitivity of 0.1 ng/ml) 6 months …
Highly sensitive thyroglobulin measurements in differentiated thyroid carcinoma management
L Giovanella - Clinical chemistry and laboratory medicine, 2008 - degruyter.com
… basis of differentiated thyroid cancer follow-up. Due to suboptimal sensitivity in older assays,
the … Differentiated thyroid carcinoma (DTC; papillary and follicular carcinoma) is generally …
the … Differentiated thyroid carcinoma (DTC; papillary and follicular carcinoma) is generally …
Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples
H Mazeh, I Mizrahi, D Halle, N Ilyayev, A Stojadinovic… - Thyroid, 2011 - liebertpub.com
… and 95% sensitivity was achieved by testing mir-221, and this may reduce the value of the
other miRNAs in the panel. However, one must realize that thyroid neoplasms are variable …
other miRNAs in the panel. However, one must realize that thyroid neoplasms are variable …
Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer
A Iervasi, G Iervasi, M Ferdeghini… - Clinical …, 2007 - Wiley Online Library
… for detecting residual thyroid tissue/recurrence/metastases after treatment for differentiated
thyroid cancer (DTC). We evaluated the clinical impact of a highly sensitive Tg assay during …
thyroid cancer (DTC). We evaluated the clinical impact of a highly sensitive Tg assay during …
… Value of Immunohistochemistry for the Detection of the BRAFV600E Mutation in Papillary Thyroid Carcinoma: Comparative Analysis with Three DNA-Based Assays
MI Ilie, S Lassalle, E Long-Mira, C Bonnetaud… - Thyroid, 2014 - liebertpub.com
… We believe that IHC is a promising screening modality showing excellent sensitivity and
specificity for the detection of BRAF V600E -mutated PTC. In this context, IHC should be …
specificity for the detection of BRAF V600E -mutated PTC. In this context, IHC should be …
[HTML][HTML] Detection of circulating BRAFV600E in patients with papillary thyroid carcinoma
CC Lubitz, S Parangi, TM Holm, MJ Bernasconi… - The Journal of Molecular …, 2016 - Elsevier
… In addition to having exponentially higher copy numbers of BRAF mRNA, digestion of
BRAF WT with TspRI in our assay further increased the sensitivity for detection. We have …
BRAF WT with TspRI in our assay further increased the sensitivity for detection. We have …
[HTML][HTML] Validation of molecular biomarkers for preoperative diagnostics of human papillary thyroid carcinoma in fine needle aspirates
SM Sadowski, V Petrenko, P Meyer, M Pusztaszeri… - Gland …, 2019 - ncbi.nlm.nih.gov
… We thus attempted to apply sensitive Single Cell-to-CT assay allowing to measure target
gene expression directly on the cell lysates which contain as little as tens to hundreds cells, …
gene expression directly on the cell lysates which contain as little as tens to hundreds cells, …
相关搜索
- thyroglobulin assay papillary thyroid carcinomas
- second generation assay papillary thyroid carcinoma
- molecular assay papillary thyroid carcinoma
- braf v600e mutation papillary thyroid carcinoma
- papillary thyroid cancer patients
- potential biomarkers papillary thyroid cancer
- papillary thyroid cancer prognosis
- disease status in papillary thyroid cancer
- diagnosis of papillary thyroid carcinoma
- brafv600e mutation in papillary thyroid carcinoma
- subset of papillary thyroid carcinomas
- low risk papillary thyroid carcinoma
- human papillary thyroid carcinoma
- peptide nucleic acid papillary thyroid carcinomas
- invasive biomarkers papillary thyroid carcinoma
- potential molecular markers papillary thyroid carcinoma